Literature DB >> 19433755

Age-associated increases in pulmonary artery systolic pressure in the general population.

Carolyn S P Lam1, Barry A Borlaug, Garvan C Kane, Felicity T Enders, Richard J Rodeheffer, Margaret M Redfield.   

Abstract

BACKGROUND: In contrast to the wealth of data on isolated systolic hypertension involving the systemic circulation in the elderly, much less is known about age-related change in pulmonary artery systolic pressure (PASP) and its prognostic impact in the general population. We sought to define the relationship between PASP and age, to evaluate which factors influence PASP, and to determine whether PASP is independently predictive of mortality in the community. METHODS AND
RESULTS: A random sample of the Olmsted County, Minn, general population (n=2042) underwent echocardiography and spirometry and was followed up for a median of 9 years. PASP was measured from the tricuspid regurgitation velocity. Left ventricular diastolic pressure was estimated with Doppler echocardiography (E/e' ratio), and arterial stiffening was assessed from the brachial artery pulse pressure. Among 1413 subjects (69%) with measurable PASP (age, 63+/-11 years; 43% male), median PASP was 26 mm Hg (25th to 75th percentile, 24 to 30 mm Hg) and increased with age (r=0.31, P<0.001). Independent predictors of PASP were age, pulse pressure, and mitral E/e' (all P< or =0.003). Increasing PASP was associated with higher mortality (hazard ratio, 2.73 per 10 mm Hg; P<0.001). In subjects without cardiopulmonary disease (any heart failure, coronary artery disease, hypertension, diabetes mellitus, or chronic obstructive lung disease), the age-adjusted hazard ratio was 2.74 per 10 mm Hg (P=0.016).
CONCLUSIONS: We provide the first population-based evidence of age-related increase in pulmonary artery pressure, its association with increasing left heart diastolic pressures and systemic vascular stiffening, and its negative impact on survival. Pulmonary artery pressure may serve as a novel cardiovascular risk factor and potential therapeutic target.

Entities:  

Mesh:

Year:  2009        PMID: 19433755      PMCID: PMC2753443          DOI: 10.1161/CIRCULATIONAHA.108.838698

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  37 in total

1.  Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study.

Authors:  S R Ommen; R A Nishimura; C P Appleton; F A Miller; J K Oh; M M Redfield; A J Tajik
Journal:  Circulation       Date:  2000-10-10       Impact factor: 29.690

2.  Extensibility of the human pulmonary trunk.

Authors:  P Harris; D Heath; A Apostolopoulos
Journal:  Br Heart J       Date:  1965-09

3.  The structure and composition of the maturing pulmonary circulation.

Authors:  J F Farrar; J Blomfield; R D Reye
Journal:  J Pathol Bacteriol       Date:  1965-07

4.  Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP).

Authors:  H M Perry; B R Davis; T R Price; W B Applegate; W S Fields; J M Guralnik; L Kuller; S Pressel; J Stamler; J L Probstfield
Journal:  JAMA       Date:  2000-07-26       Impact factor: 56.272

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

6.  Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects.

Authors:  B M McQuillan; M H Picard; M Leavitt; A E Weyman
Journal:  Circulation       Date:  2001-12-04       Impact factor: 29.690

7.  Participation bias in a population-based echocardiography study.

Authors:  Steven J Jacobsen; Douglas W Mahoney; Margaret M Redfield; Kent R Bailey; John C Burnett; Richard J Rodeheffer
Journal:  Ann Epidemiol       Date:  2004-09       Impact factor: 3.797

8.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.

Authors:  Margaret M Redfield; Steven J Jacobsen; John C Burnett; Douglas W Mahoney; Kent R Bailey; Richard J Rodeheffer
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

10.  Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study.

Authors:  Gary F Mitchell; Helen Parise; Emelia J Benjamin; Martin G Larson; Michelle J Keyes; Joseph A Vita; Ramachandran S Vasan; Daniel Levy
Journal:  Hypertension       Date:  2004-05-03       Impact factor: 10.190

View more
  130 in total

1.  Effect of aging on cardiac function during cold stress in humans.

Authors:  Thad E Wilson; Zhaohui Gao; Kari L Hess; Kevin D Monahan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-04-07       Impact factor: 3.619

2.  Pulmonary hypertension as an independent predictor of cardiovascular mortality and events in hemodialysis patients.

Authors:  Zhilian Li; Shuangxin Liu; Xinling Liang; Wenjian Wang; Hongwen Fei; Penghua Hu; Yuanhan Chen; Lixia Xu; Ruizhao Li; Wei Shi
Journal:  Int Urol Nephrol       Date:  2013-06-21       Impact factor: 2.370

3.  Pulmonary hypertension in a stable community-based COPD population.

Authors:  Vadim Fayngersh; Fotios Drakopanagiotakis; F Dennis McCool; James R Klinger
Journal:  Lung       Date:  2011-08-04       Impact factor: 2.584

4.  Exercise-induced interstitial pulmonary edema at sea-level in young and old healthy humans.

Authors:  Bryan J Taylor; Alex R Carlson; Andrew D Miller; Bruce D Johnson
Journal:  Respir Physiol Neurobiol       Date:  2013-11-04       Impact factor: 1.931

Review 5.  Pulmonary vasodilation in acute and chronic heart failure: empiricism and evidence.

Authors:  Maya Guglin
Journal:  Curr Heart Fail Rep       Date:  2011-09

Review 6.  Biochemical markers of aging for longitudinal studies in humans.

Authors:  Peter M Engelfriet; Eugène H J M Jansen; H Susan J Picavet; Martijn E T Dollé
Journal:  Epidemiol Rev       Date:  2013-02-04       Impact factor: 6.222

7.  Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD.

Authors:  Sankar D Navaneethan; Jason Roy; Kelvin Tao; Carolyn S Brecklin; Jing Chen; Rajat Deo; John M Flack; Akinlolu O Ojo; Theodore J Plappert; Dominic S Raj; Ghulam Saydain; James H Sondheimer; Ruchi Sood; Susan P Steigerwalt; Raymond R Townsend; Raed A Dweik; Mahboob Rahman
Journal:  J Am Soc Nephrol       Date:  2015-09-18       Impact factor: 10.121

Review 8.  Is universal grading of diastolic function by echocardiography feasible?

Authors:  Zoran B Popović; Kimi Sato; Milind Y Desai
Journal:  Cardiovasc Diagn Ther       Date:  2018-02

9.  Elevated pulmonary arterial systolic pressure in patients with sarcoidosis: prevalence and risk factors.

Authors:  Aggeliki Rapti; Vasileios Kouranos; Elias Gialafos; Konstantina Aggeli; John Moyssakis; Anastasios Kallianos; Charalampos Kostopoulos; Ourania Anagnostopoulou; Petros P Sfikakis; Athol U Wells; George E Tzelepis
Journal:  Lung       Date:  2012-12-11       Impact factor: 2.584

10.  Right Ventricular Function, Right Ventricular-Pulmonary Artery Coupling, and Heart Failure Risk in 4 US Communities: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Kotaro Nochioka; Gabriela Querejeta Roca; Brian Claggett; Tor Biering-Sørensen; Kunihiro Matsushita; Chung-Lieh Hung; Scott D Solomon; Dalane Kitzman; Amil M Shah
Journal:  JAMA Cardiol       Date:  2018-10-01       Impact factor: 14.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.